Mahana Therapeutics Inc.. (3/12/24). "Press Release: Mahana Therapeutics Acquires Cara Care to Become a Global Leader in the Digital Treatment of Chronic Conditions". San Francisco, CA. |
2024-03-12 |
Sosei Group Corporation (d/b/a Sosei Heptares). (3/11/24). "Press Release: Boehringer Ingelheim and Sosei Heptares Join Forces to Develop First-in-class Treatments Targeting All Symptoms of Schizophrenia". Ingelheim, Tokyo & Cambridge. |
2024-03-11 |
Precisio Biotix Therapeutics, Inc.. (3/1/24). "Press Release: Precisio Biotix Therapeutics Acquires London-headquartered CC Bio, Adding World-class Antibacterial Platform and Top Scientists". Dover, DE. |
2024-03-01 |
Neobe Therapeutics Ltd.. (2/29/24). "Press Release: Neobe Therapeutics Raises over $2m for Synthetic Biology Enabled Tumour Microenvironment Remodelling". |
2024-02-29 |
Cresset Biomolecular Discovery Ltd.. (2/21/24). "Press Release: Cresset Announces Global Collaboration with Enamine on New Virtual Screening Drug Discovery Technology". Cambridge. |
2024-02-21 |
Agilent Technologies Inc.. (2/21/24). "Press Release: Agilent CEO Mike McMullen to Retire Agilent CrossLab Group – President Padraig McDonnell Named CEO-Elect". Santa Clara, CA. |
2024-02-21 |
MIP Discovery Ltd.. (2/19/24). "Press Release: MIP Discovery Closes £7M Series A Financing to Drive Commercialization in Cell and Gene Therapy Space". |
2024-02-19 |
Newcells Biotech Ltd.. (2/14/24). "Press Release: Biotech Raises further £2.35m for Lab Models that Help Avoid Animal Testing". |
2024-02-14 |
Earlybird VC Management GmbH & Co KG. (2/14/24). "Press Release: Earlybird Health Closes Fresh Fund of EUR 173m". Berlin & Cologne. |
2024-02-14 |
Candriam. (2/13/24). "Press Release: Candriam Strengthens Thematic Investing Expertise with New Appointments and Announces Leadership Transition". London. |
2024-02-13 |
Amply Discovery Ltd.. (2/12/24). "Press Release: Amply Discovery Raises £1.4m in Innovate UK Grant Funding to Tackle Complex Diseases". |
2024-02-12 |
BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London. |
2024-02-08 |
Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". |
2024-02-08 |
Sablebio Ltd. (Sable Bio). (2/6/24). "Press Release: Sable Bio Raises £1.5m Pre-seed Round to Transform Drug Discovery Safety Assessments". London. |
2024-02-06 |
Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London. |
2024-02-05 |
Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". |
2024-02-01 |
Silence Therapeutics plc. (1/31/24). "Press Release: Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference". London. |
2024-01-31 |
Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. |
2024-01-30 |
Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. |
2024-01-30 |
IMU Bioscience (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. |
2024-01-24 |
BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. |
2024-01-24 |
Sano Genetics Ltd.. (1/22/24). "Press Release: Sano Genetics Raises $11.4 Million Led by Plural to Power Precision Medicine Revolution with Seamless Trials". Cambridge. |
2024-01-22 |
Enamine Ltd.. (1/11/24). "Press Release: Enamine and SyntheticGestalt to Collaborate on the Creation of AI-based Model to Facilitate Drug Discovery". Tokyo & Kyiv. |
2024-01-11 |
Mesenbio Ltd.. (1/9/24). "Press Release: DSW Ventures and NG Bio Lead £1.4m Investment into University of York Spinout Mesenbio". |
2024-01-09 |
Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion". |
2024-01-09 |
GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio". |
2024-01-09 |
CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. |
2024-01-05 |
Enara Bio Ltd.. (1/4/24). "Press Release: Boehringer Ingelheim Licenses Multiple Dark Antigens from Enara Bio to Develop Off-the-Shelf Immunotherapies for Non-small Cell Lung Cancer (NSCLC)". Oxford. |
2024-01-04 |
CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA. |
2024-01-03 |
Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg. |
2024-01-03 |
Allorion Therapeutics Inc.. (1/2/24). "Press Release: Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca". Natick, MA. |
2024-01-02 |
Apollo Therapeutics. (1/2/24). "Press Release: Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million". Cambridge & Boston, MA. |
2024-01-02 |
AstraZeneca plc. (12/26/23). "Press Release: AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". |
2023-12-26 |
Gracell Biotechnologies Inc.. (12/26/23). "Press Release: Gracell Biotechnologies to Be Acquired by AstraZeneca, furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". San Diego, CA, Suzhou & Shanghai. |
2023-12-26 |
Metrion Biosciences Ltd.. (12/20/23). "Press Release: Metrion Biosciences Closes £3.7m New Equity Financing". Cambridge. |
2023-12-20 |
Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona. |
2023-12-20 |
GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London. |
2023-12-20 |
CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen. |
2023-12-19 |
LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. |
2023-12-19 |
Sofinnova Partners. (12/13/23). "Press Release: Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups". Paris. |
2023-12-13 |
AstraZeneca plc. (12/12/23). "Press Release: AstraZeneca to Acquire Icosavax, Including Potential First-in-Class RSV and hMPV Combination Vaccine with Positive Phase II Data". |
2023-12-12 |
Icosavax, Inc.. (12/12/23). "Press Release: Icosavax, Inc. Announces Agreement to Be Acquired by AstraZeneca". Seattle, WA. |
2023-12-12 |
Antabio S.A.S.. (12/12/23). "Press Release: Antabio Raises €25 Million in Series B Financing". Labège. |
2023-12-12 |
Novogene. (12/8/23). "Press Release: Novogene Expands Its European Operations with New Genomics Facility at the IZB in Munich, Germany". Martinsried. |
2023-12-08 |
Exscientia plc. (12/5/23). "Press Release: Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza". Oxford. |
2023-12-05 |
UK Government (Dept. for Science, Innovation and Technology). (12/5/23). "Press Release: Government Publishes £2 Billion Vision for Engineering Biology to Revolutionise Medicine, Food and Environmental Protection". |
2023-12-05 |
Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA. |
2023-12-05 |
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". |
2023-12-05 |
Refeyn Ltd.. (11/30/23). "Press Release: Refeyn Launches KaritroMP for Rapid and Reproducible Characterization of Large Viral Vectors". Oxford. |
2023-11-30 |
Freeline Therapeutics Holdings plc. (11/22/23). "Press Release: Syncona to Acquire Freeline Therapeutics". London. |
2023-11-22 |
Quotient Therapeutics. (11/21/23). "Press Release: Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics". Cambridge, MA. |
2023-11-21 |
Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA. |
2023-11-21 |
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". |
2023-11-21 |
Exscientia plc. (11/21/23). "Press Release: Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference". Oxford. |
2023-11-21 |
Da Vinci Labs. (11/20/23). "Press Release: The European ‘SynBee Pitch Competition’ Will Reward Innovative Synthetic Biology Projects at SynBee Day 2024. Da Vinci Labs Is the New Coordinator of the SynBee Project". Reugny. |
2023-11-20 |
Gracell Biotechnologies Inc.. (11/16/23). "Press Release: Gracell Biotechnologies to Participate in Inaugural Cell Therapy for Autoimmune Disease Summit". San Diego, CA, Suzhou & Shanghai. |
2023-11-16 |
eXmoor Pharma Concepts Ltd.. (11/16/23). "Press Release: eXmoor Appoints Matthew Paterson as First Chief Commercial Officer". Bristol. |
2023-11-16 |
T-Therapeutics Ltd.. (11/15/23). "Press Release: T-Therapeutics Raises £48 Million Series A for Development of Next Generation TCR Therapeutics to Transform Cancer Treatment". Cambridge. |
2023-11-15 |
Glox Therapeutics Ltd.. (11/14/23). "Press Release: Glox Therapeutics Secures £4.3M Seed Funding to Develop Precision Antimicrobials Targeting Drug-resistant Bacteria". Glasgow. |
2023-11-14 |
Autifony Therapeutics Ltd.. (11/14/23). "Press Release: Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders". Stevenage. |
2023-11-14 |
ViaNautis Bio Ltd.. (11/13/23). "Press Release: ViaNautis Bio Announces $25 Million Series A Financing to Drive the Next Generation of Genetic Nanomedicines". Cambridge. |
2023-11-13 |
Cromatic Inc.. (11/9/23). "Press Release: Cromatic Closes $5.3 Million in Oversubscribed Seed Round to Modernize Life Science R&D Outsourcing". Palo Alto, CA. |
2023-11-09 |
AstraZeneca plc. (11/9/23). "Press Release: AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity [This press release is intended for investors and business / science media]". |
2023-11-09 |
Valneva S.E.. (11/7/23). "Press Release: Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference". Saint Herblain. |
2023-11-07 |
Memo Therapeutics AG. (11/02/23). "Press Release: Memo Therapeutics AG Raises CHF 25 Million Series C Financing to Complete Phase II Clinical Development of AntiBKV for BKV Infection in Renal Transplant Patients". Schlieren. |
2023-11-02 |
Danforth Advisors, LLC. (11/2/23). "Press Release: Danforth Advisors Expands to Europe with Launch of UK Operations". Waltham, MA. |
2023-11-02 |
Danaher Corporation. (10/31/23). "Press Release: Danaher Appoints Christopher Riley to Executive Vice President for Biotechnology". Washington D.C.. |
2023-10-31 |
Bicycle Therapeutics plc. (10/30/23). "Press Release: Bicycle Therapeutics to Participate in Upcoming Investor Conferences". Cambridge. |
2023-10-30 |
MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY. |
2023-10-30 |
Aiolos Bio, Inc.. (10/24/23). "Press Release: Aiolos Bio Launches with $245 Million Series A Investment to Advance Development of Novel, Phase 2-Ready TSLP Antibody". San Francisco, CA & London. |
2023-10-24 |
OrbiMed Advisors LLC. (10/24/23). "Press Release: OrbiMed Raises $4.3 Billion Across Private Investment Funds". New York, NY. |
2023-10-24 |
Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki. |
2023-10-23 |
GSK plc. (10/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20089". London. |
2023-10-20 |
bioMérieux S.A.. (10/19/23). "Press Release: bioMérieux Makes Strategic Investment in Oxford Nanopore". Oxford & Marcy-l’Etoile. |
2023-10-19 |
Cresset Biomolecular Discovery Ltd.. (10/18/23). "Press Release: Cresset Targets International Growth with Innovate UK Scaleup Programme". Cambridge. |
2023-10-18 |
Exscientia plc. (10/17/23). "Press Release: Parker Moss to Join Exscientia as EVP, Corporate Development". Oxford. |
2023-10-17 |
Refeyn Ltd.. (10/17/23). "Press Release: Refeyn Expands the Analytical Possibilities for High Concentration Samples by MassFluidix HC". Oxford. |
2023-10-17 |
Antiverse Ltd.. (10/16/23). "Press Release: Antiverse and GlobalBio, Inc. Extend Collaboration to Advance Antibody Cancer Therapeutics". Cardiff & Cambridge, MA. |
2023-10-16 |
Sosei Group Corporation (d/b/a Sosei Heptares). (10/10/23). "Press Release: Sosei Heptares and PharmEnable Therapeutics Expand Drug Discovery Collaboration". Tokyo & Cambridge. |
2023-10-10 |
AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London. |
2023-10-09 |
LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. |
2023-10-09 |
Medicines Discovery Catapult (MDC). (10/5/23). "Press Release: UK Launches Its First National Total-body PET Platform for Drug Discovery". |
2023-10-05 |
Markes International Ltd.. (10/5/23). "Press Release: Schauenburg Analytics Ltd Announces Appointment of New CEO". |
2023-10-05 |
EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. |
2023-10-04 |
Exscientia plc. (10/3/23). "Press Release: Exscientia Details Pipeline Prioritisation Strategy". Oxford. |
2023-10-03 |
Refeyn Ltd.. (10/2/23). "Press Release: Refeyn Announces Appointment of New CEO". Oxford. |
2023-10-02 |
Mogrify Ltd.. (10/2/23). "Press Release: Mogrify Extends Series A Financing to $46 Million USD". Cambridge. |
2023-10-02 |
Broken String Biosciences Ltd.. (10/2/23). "Press Release: Broken String Biosciences Strengthens Senior Leadership Team to Accelerate Product Development and Commercialization". Cambridge. |
2023-10-02 |
Laverock Therapeutics Ltd.. (9/28/23). "Press Release: Laverock Therapeutics Raises £13.5M to Develop Unique Gene Silencing Platform for Programmable Advanced Therapies". |
2023-09-28 |
Sartorius AG. (9/28/23). "Press Release: Sartorius Forms Partnership with Sparta Biodiscovery on Novel Nanoparticle Analysis Platform". Göttingen. |
2023-09-28 |
BioProtect Ltd.. (9/27/23). "Press Release: BioProtect Secures $28M to Commercialize Its Biodegradable Balloon for Rectal Protection During Prostate Cancer Radiation Therapy". Tzur Igal. |
2023-09-27 |
Cytel Inc.. (9/26/23). "Press Release: Cytel Continues Expansion of Market Access and Medical Communication Capabilities with the Acquisition of Co.faktor". Waltham, MA. |
2023-09-26 |
Biosynth AG. (9/25/23). "Press Release: Biosynth Extends its Offering to Multi-Kilogram GMP Peptide Synthesis through the Acquisition of Pepceuticals". Staad. |
2023-09-25 |
Argobio S.A.S.. (9/25/23). "Press Release: Northern Gritstone and Argobio Studio Back Sheffield University Spin-out Crucible Therapeutics". Paris, Manchester & Sheffield. |
2023-09-25 |
Exscientia plc. (9/20/23). "Press Release: Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany". Oxford. |
2023-09-20 |
Oxford Biomedica plc. (9/20/23). "Press Release: Oxford Biomedica and Institut Mérieux Enter into Exclusive Negotiations with Respect to the Proposed Acquisition by Oxford Biomedica of ABL Europe". Oxford. |
2023-09-20 |
BenevolentAI. (9/20/23). "Press Release: BenevolentAI Signs Strategic Collaboration with Merck". London. |
2023-09-20 |
AstraZeneca plc. (9/20/23). "Press Release: Alexion Completes Purchase and Licence Agreement for Early-stage Rare Disease Gene Therapy Portfolio from Pfizer". |
2023-09-20 |
Bionow (The Centre of Excellence for Life Sciences Ltd. trading as Bionow). (9/20/23). "Press Release: 2023 BioCap Conference Pitching Competition Finalists Announced". |
2023-09-20 |